Drugs / A vaccine composed of a recombinant S1 antigen
A vaccine composed of a recombinant S1 antigen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05016934 | Nov 2021 → Mar 2022 | COVID-19 | Hospital do Coracao | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | A vaccine composed of a recombinant S1 antigen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05016934 ↗ |
| Modality | Vaccine | “a vaccine composed of a recombinant S1 antigen” NCT05016934 ↗ |